· View the paper (DOI)
Researchers identified the protein BRD9 as essential for the survival of synovial sarcoma tumours. They developed a new drug that degrades this protein, which is also responsible for driving cancer development, and found it to be effective in blocking tumour progression.
Coverage from 2 institutions